Latest Breaking News On - Executive john sperzel - Page 1 : comparemela.com

By Denny Jacob T2 Biosystems shares plummeted 47% to $9.19 on forecasts of lower revenue in the third-quarter. The stock is down 93% on the year so far..

John sperzelDenny jacobDevelopment authorityBiomedical advanced researchExecutive john sperzelArticle normalMedical equipment suppliesHealthcare life sciencesMedical diagnostic equipment suppliesMedical devices apparatusDiagnostic therapeutic devicesFinancial performanceShare price movement disruptionsCorporate industrial newsContent typesFactiva filters